Skip to main content
H.R. 6301 118th Congress House

Cancer Drug Parity Act of 2023

Official title: To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a pla… Show full official titleShow less

Official title: To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Introduced: November 8, 2023 Introduced by: Glenn Grothman Republican · Wisconsin See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2023
Referred to the House Committee on Education and the Workforce.
Nov 8, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 8, 2023

Referred to the House Committee on Education and the Workforce.

 Related & companion bills 1
  • S 2039 Identical bill Cancer Drug Parity Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 27
All 27 Democratic 15 Republican 2
D
Davids, Sharice
Kansas · Dec 10, 2024
Spanberger, Abigail
· Nov 26, 2024
 D
Davis, Donald G.
North Carolina · Oct 25, 2024
 D
Larson, John B.
Connecticut · Oct 22, 2024
 D
Lieu, Ted
California · Oct 15, 2024
 D
Moore, Gwen
Wisconsin · Oct 15, 2024
Caraveo, Yadira
· Jul 23, 2024
Kilmer, Derek
· Jun 27, 2024
Posey, Bill
· Jun 27, 2024
 D
Pappas, Chris
New Hampshire · May 22, 2024
Napolitano, Grace
· Mar 12, 2024
Kuster, Ann
· Jan 25, 2024
 D
Barragán, Nanette Diaz
California · Jan 10, 2024
 D
Raskin, Jamie
Maryland · Jan 10, 2024
Trone, David
· Jan 10, 2024
 D
Castor, Kathy
Florida · Dec 11, 2023
 D
Connolly, Gerald E.
Virginia · Dec 11, 2023
 D
Clarke, Yvette D.
New York · Dec 5, 2023
Allred, Colin
· Nov 30, 2023
 D
Brownley, Julia
California · Nov 30, 2023
 D
Panetta, Jimmy
California · Nov 30, 2023
 R
Bilirakis, Gus M.
Florida · Nov 8, 2023
 D
Bonamici, Suzanne
Oregon · Nov 8, 2023
 R
Fitzpatrick, Brian K.
Pennsylvania · Nov 8, 2023
Higgins, Brian
· Nov 8, 2023
 D
Matsui, Doris O.
California · Nov 8, 2023
 D
Morelle, Joseph D.
New York · Nov 8, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6301: Cancer Drug Parity Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6301/
MLA
"H.R. 6301: Cancer Drug Parity Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6301/.
Bluebook (legal)
H.R. 6301, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6301/.
Markdown link
[H.R. 6301: Cancer Drug Parity Act of 2023](https://openamerica.io/bill/118-HR-6301/)
Report a problem